H.I.G. Capital, LLC completed the acquisition of Zimmer Biomet Spine, Inc. from ZimVie Inc..
April 31, 2024
Share
H.I.G. Capital, LLC entered into an Equity Purchase Agreement to acquire Zimmer Biomet Spine, Inc. from ZimVie Inc. (NasdaqGS:ZIMV) for approximately $380 million on December 15, 2023. The purchase price to be paid to ZimVie in connection with the Transaction is $375,000,000, comprised of $315,000,000 in cash, subject to certain customary adjustments as set forth in the Purchase Agreement, and $60,000,000 in the form of a subordinated promissory note payable by Purchaser to ZimVie. In the event that the Seller shall terminate this Agreement pursuant then Purchaser shall promptly, but in no event later than ten Business Days after the date of such termination, pay or cause to be paid to Seller a termination fee of $24,375,000 in cash. The Purchase Agreement provides that completion of the Transaction is subject to the satisfaction or waiver of customary closing conditions, including, among other things, obtaining certain required regulatory approvals and the waiting period applicable to the consummation of the Transactions under the HSR Act shall have expired or early termination thereof shall have been granted. In addition, Purchaser?s obligation to consummate the Transaction is further conditioned upon the exercise by ZimVie of the French Put Option. The transaction is expected to close in the first half of 2024. Net Proceeds Will be Used to Pay Down Debt and Support Dental Growth Initiatives. Harris Siskind, Alex Clavero, Taylor Berman and Griffin Doty of McDermott Will & Emery LLP acted as legal advisor to H.I.G. Capital, LLC. Robert I. Townsend III, O. Keith Hallam III, Sanjay Murti, Christopher J. Kelly, J. Leonard Teti II, Jonathan J. Katz, David J. Kappos, Matthew Morreale, Margaret T. Segall, Michael L. Arnold and Kimberley S. Drexler, Jesse M. Weiss and Benjamin G. Joseloff of Cravath, Swaine & Moore LLP acted as legal advisor to ZimVie. Centerview Partners is serving as exclusive financial advisor to ZimVie.
H.I.G. Capital, LLC completed the acquisition of Zimmer Biomet Spine, Inc. from ZimVie Inc. (NasdaqGS:ZIMV) on April 1, 2024.
ZimVie Inc. is a global life sciences company in the dental market. The Company develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. The Company works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems. The key products in its dental implant systems portfolio include the T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, BellaTek Encode Impression System, and Puros Allograft Particulate. The Company markets its products in about 70 countries in North America, Europe, Latin America and Asia.